Menu
GWAS Study

Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.

Stein JL, Hua X, Morra JH et al.

20197096 PubMed ID
GWAS Study Type
742 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SJ
Stein JL
HX
Hua X
MJ
Morra JH
LS
Lee S
HD
Hibar DP
HA
Ho AJ
LA
Leow AD
TA
Toga AW
SJ
Sul JH
KH
Kang HM
EE
Eskin E
SA
Saykin AJ
SL
Shen L
FT
Foroud T
PN
Pankratz N
HM
Huentelman MJ
CD
Craig DW
GJ
Gerber JD
AA
Allen AN
CJ
Corneveaux JJ
SD
Stephan DA
WJ
Webster J
DB
DeChairo BM
PS
Potkin SG
JC
Jack CR
WM
Weiner MW
TP
Thompson PM
Chapter II

Abstract

Summary of the research findings

In a genome-wide association study of structural brain degeneration, we mapped the 3D profile of temporal lobe volume differences in 742 brain MRI scans of Alzheimer's disease patients, mildly impaired, and healthy elderly subjects. After searching 546,314 genomic markers, 2 single nucleotide polymorphisms (SNPs) were associated with bilateral temporal lobe volume (P<5 x 10(-7)). One SNP, rs10845840, is located in the GRIN2B gene which encodes the N-methyl-d-aspartate (NMDA) glutamate receptor NR2B subunit. This protein - involved in learning and memory, and excitotoxic cell death - has age-dependent prevalence in the synapse and is already a therapeutic target in Alzheimer's disease. Risk alleles for lower temporal lobe volume at this SNP were significantly over-represented in AD and MCI subjects vs. controls (odds ratio=1.273; P=0.039) and were associated with mini-mental state exam scores (MMSE; t=-2.114; P=0.035) demonstrating a negative effect on global cognitive function. Voxelwise maps of genetic association of this SNP with regional brain volumes, revealed intense temporal lobe effects (FDR correction at q=0.05; critical P=0.0257). This study uses large-scale brain mapping for gene discovery with implications for Alzheimer's disease.

162 European ancestry Alzheimer's disease cases, 343 European ancestry amnestic mild cognitive impairment cases, 193 European ancestry healthy elderly controls

Chapter III

Study Statistics

Key metrics and study information

742
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.